Artificial intelligence software developed by Pangea Biomed can predict the chances that a patient will respond to cancer treatment by looking at tumour histopathology images.That is the finding of a study published in Nature Cancer, which tested the ability of Pangea Bio’s ENLIGHT-DP to predict patients’ responses based on tumour samples that the software had never been trained on or seen before.
